group iii consisted of 191 women with pathological node-positive breast cancer who received adjuvant cyclophosphamide , methotrexate , and 5-fluorouracil ( cmf ) ( group iiia ) or cmf plus prednisone ( 7.5 mg per day ) and ovarian ablation ( group iiib ) .
C0016360
5-fluorouracil
C0950521
cmf